Insulin-like growth factor-I (IGF-I), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF) and ciliary neurotrophic factor (CNTF) are multifunctional growth factors which are found in the CNS. Oligodendroglia are the cells that form and maintain myelin sheaths and many in vitro experiments have shown that these growth factors promote the proliferation, differentiation and survival of cells in the oligodendroglial lineage. Since myelin breakdown is often severe in multiple sclerosis (MS), the possibility of growth factor use in the treatment of MS has been considered and recently, IGF-I treatment has been shown to reduce lesion severity and promote myelin regeneration in experimental autoimmune encephalomyelitis (EAE), an animal model of MS. This review briefly summarizes the structural characteristics of these growth factors and the actions which might help reduce oligodendrocyte-myelin sheath injury in MS and promote myelin regeneration.
Levi Montalcini R. (1987) The nerve growth factor 35 years later. Science237: 1154-1162.
2.
Rotwein P. (1991) Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors5: 3-18.
3.
Sendtner M. et al. (1994) Ciliary neurotrophic factor. J Neurobiol25: 1436-1453.
4.
Klagsbrun M. (1989) The fibroblast growth factor family: Structural and biological properties. Prog Growth Factor Res1: 207-235.
5.
Eckenstein FP (1994) Fibroblast growth factors in the nervous system. J. Neurobiol25: 1467-1480.
6.
Korsching S. (1993) The neurotrophic factor concept: A re-examination. J Neurosci13: 2739-2748.
7.
Nishi R. (1994) Neurotrophic factors: Two are better than one. Science265: 1052-1053.
8.
Compston A. (1994) Future prospects for the management of multiple sclerosis. Ann Neurol36 Suppl. S146-150.
9.
Grinspan JB et al. (1994) Protein growth factors as potential therapies for central nervous system demyelinative disorders. Ann Neurol36Suppl. S140-142.
10.
Lubetski C. (1994) Sclérose en plaques: Rôle des facteurs de croissance et de la remyélinisation. La Presse Medicale23: 1577-1581.
11.
Utz U., McFarland HF (1994) The role of T cells in multiple sclerosis: Implications for therapies targeting the T cell receptor. J Neuropathol Exp Neurol53: 351-358.
12.
Olsson T. (1995) Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology45 Suppl 6: S11-15.
13.
Lassmann H. , Suchanek G., Ozawa K. (1994) Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis . Ann Neurol36 Suppl. S42-46.
14.
Li H., Cuzner ML, Newcombe J. (1996) Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol Appl Neurobiol22: 207-215.
15.
Zajicek J., Compston A. (1995) Mechanisms of damage and repair in multiple sclerosis - a review. Mult Scler1: 61-72.
16.
Bruck W. et al. (1994) Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol35: 65-73.
17.
Rodriguez M. , Scheithauer BW, Forbes G., Kelly PJ (1993) Oligodendrocyte injury is an early event in lesions of multiple sclerosis . Mayo Clin Proc68: 627-636.
Liu X. et al. (1994) Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis. Mol Cell Neurosci5: 418-430.
20.
Klempt ND et al. (1992) Expression of insulin-like growth factor-binding protein 2 (IGF-BP-2) following transient hypoxia-ischemia in the infant rat brain. Mol Brain Res15: 55 - 61.
21.
Komoly S., Hudson LD, Webster HdeF., Bondy CA (1992) Insulin-growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA89: 1894-1898.
22.
Lee W.-H, Clemens JA, Bondy CA (1992) Insulin-like growth factors in the response to cerebral ischemia. Mol Cell Neurosci3: 36-43.
23.
Gehrmann J. et al. (1994) Expression of insulin-like growth factor-I and related peptides during motoneuron regeneration. Exp Neurol128: 202-210.
24.
Hagg T. et al. (1994) Neurotrophic factors, growth factors, and central nervous system trauma. In: Salzman SK, Faden AI (eds). The Neurobiology of Central Nervous System Trauma. Oxford University Press: New York. pp 245-265.
25.
Logan A., Oliver JJ, Berry M. (1995) Growth factors in CNS repair and regeneration. Prog Growth Factor Res5: 379-405.
26.
Mocchetti I. , Wrathall JM (1995) Neurotrophic factors in central nervous system trauma. J Neurotrauma12: 853- 870.
27.
Yao D-L. et al. (1995) Cryogenic spinal cord injury induces astrocytic gene expression of insulin-like growth factor I and insulin-like growth factor binding protein 2 during myelin regeneration . J Neurosci Res40: 647-659.
28.
Guan J. et al. (1996) The movement of IGF-I into the brain parenchyma after hypoxic-ischaemic injury. Neuroreport7: 632-636.
29.
Yao D., Liu X., Hudson LD, Webster HdeF. (1995) Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA92: 6190-6194.
30.
Liu X., Yao D.-L. WebsterHdeF. (1995) Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis . Mult Scler1: 2-9.
Salmon WD, Daughaday WH (1957) A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med49: 825-836.
34.
Lee W.-H, Javedan S., Bondy CA (1992) Coordinate expression of insulin-like growth factor system components by neurons and neuroglia during retinal and cerebellar development . J Neurosci12: 4737-4744.
35.
Ballotti R. et al. (1987) Insulin-like growth factor I in cultured rat astrocytes: Expression of the gene and receptor tyrosine kinase. EMBO J6: 3622-3639.
36.
Chernausek SD (1993) Insulin-like growth factor-I (IGF-I) production by astroglial cells: Regulation and importance for epidermal growth factor-induced cell replication. J Neurosci Res34: 189-197.
37.
McMorris FA , Smith TM, DeSalvo S., Furlanetto RW (1986) Insulin-like growth factor I/somatomedin C: A potent inducer of oligodendrocyte development. Proc Natl Acad Sci USA83: 822-826.
38.
McMorris FA , Dubois-Dalcq M. (1988) Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat progenitor cells developing in vitro. J Neurosci Res21: 199-209.
39.
Saneto RP, Low KG, Melner MH, De Vellis J. (1988) Insulin/insulin-like growth factor I and other epigenetic modulators of myelin basic protein expression in isolated oligodendrocyte progenitor cells. J Neurosci Res21: 210-219.
40.
Barres BA et al. (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell70: 31-46.
41.
Barres BA, Schmid R., Sendnter M., Raff MC ( 1993) Multiple extracellular signals are required for long-term oligodendrocyte survival. Development118: 283-295.
42.
Scolding NJ , Compston DA (1995) Growth factors fail to protect rat oligodendrocytes against humoral injury in vitro. Neurosci Lett183: 75-78.
43.
Mozell RL, McMorris FA (1991) Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures. J Neurosci Res30: 382 - 390.
44.
Roth GA, Spada V., Hamill K., Bornstein MB (1995) Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue. Dev Brain Res88: 102-108.
45.
Godfraind C. , Friedrich VL, Holmes KV, Dubois-Dalcq M. (1989) In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice. J Cell Biol109: 2405-2416.
46.
Noble M., Wolswijk G. (1992) Development and regeneration in the O-2A lineage: Studies in vitro and in vivo. J Neuroimmunol40: 287 - 294.
47.
Knapp PE, Skoff RP, Booth CS (1993) Essential prerequisities for remyelination of oligodendrocytes: Division, motility, and structural rearrangement. Adv Neurol59: 105-112.
48.
Wood PM, Mora J. ( 1993) Source of remyelinating oligodendrocytes. Adv Neurol59: 113-123.
49.
Armstrong RC et al. (1992) Pre-oligodendrocytes from adult human CNS. J Neurosci12: 1538-1547.
50.
Prabhakar S. et al. (1995) Phenotypic and cell cycle properties of human oligodendrocytes in vitro. Brain Res672: 159-169.
51.
Scolding NJ et al. (1995) A proliferative adult human oligodendrocyte progenitor. Neuroreport6: 441-445.
52.
Wood PM, Bunge RP (1984) Evidence that axons are mitogenic for oligodendrocytes isolated from adult animals. Nature320: 756-758.
53.
Chen SJ, De Vries GH (1989) The mitogenic effect of the axolemma-enriched fraction on cultured oligodendrocytes. J Neurochem52: 325.
54.
Badache A., Pal S., DeVries GH (1995) Biochemical study of basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) in axolemma-enriched fractions . J Neurochem64: S94.
55.
Suy S., Russell T., DeVries GH (1995) Low affinity bFGF receptors on oligodendrocytes are not required for proliferation stimulated by axolemma-enriched fractions . J Neurochem64: S94.
56.
Ang LC, Bhaumick B., Juurlink Bhj. (1993) Neurite promoting activity of insulin, insulin-like growth factor I and nerve growth factor on spinal motoneurons is astrocyte dependent. Dev Brain Res74: 83 - 88.
57.
Chernausek SD, Murray MA, Cheung PT (1993) Expression of insulin-like growth factor binding protein-4 (IGFBP-4) by rat neural cells - Comparison to other IGFBPs. Regul Pept48: 123-132.
58.
Bondy CA, Werner H., Roberts CT, LeRoith D. (1992) Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: Comparison with insulin-like growth factors I and II. Neuroscience46: 909-923.
59.
Grant MB et al. (1993) Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: Comparative studies with basic fibroblast growth factor. Diabetologia36: 282-291.
60.
Skoff RP, Tolland D., Nast E. ( 1980) Pattern of myelination and distribution of neuroglial cells along the developing optic system of the rat and rabbit. J Comp Neurol191: 237-253.
61.
Xu et al. (1995) Expression of functional insulin-like growth factor-1 receptor on lymphoid cell subsets of rats. Immunology85: 394-399.
62.
Stuart CA et al. (1991) Insulin-like growth factor-I binds to selectivity to human peripheral blood monocytes and B-lymphocytes. J Clin Endocrinol Metab72: 1117-1122.
63.
Jin G.-F, Guo Y.-S, Ball C., Houston CW (1993) Insulin-like growth factors enhance phagocytosis by human neutrophils in vitro. Regulatory Peptides49: 125-131.
64.
Roldan A. et al. (1989) Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin . Immunol Lett20: 5 - 8.
65.
Loret C. et al. (1991) FGFs stimulate IGF binding protein synthesis without affecting IGF synthesis in rat astro-blasts in primary culture. Glia4: 378-383.
66.
Rubini et al. (1994) Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene . Exp Cell Res211: 374-379.
67.
DeAngelis T. , Ferber A., Baserga R. (1995) Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J Cell Physiol164: 214-221.
68.
Bondy CA (1991) Transient IGF-I gene expression during the maturation of functionally related central projection neurons. J Neurosci11: 3442-3455.
69.
Bartlett WP , Li X-S., Williams M., Benkovic S. (1991) Localization of insulin-like growth factor-1 mRNA in murine central nervous system during postnatal development . Dev Biol147: 239-250.
70.
De Pablo F. , de la Rosa E. (1995) The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors . Trends Neurosci18: 143-150.
71.
Mathews LS et al. (1988) Growth enhancement of transgenic mice expressing human insulin-like growth factorI. Endocrinology123: 2827-2833.
72.
Carson MJ, Behringer RR, Brinster RL, McMorris FA (1993) Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron10: 729 - 740.
73.
Ye P., Carson J., D'Ercole AJ (1995) Insulin-like growth factor-I influences the initiation of myelination: Studies of the anterior commissure of transgenic mice. Neurosci Lett201: 235-238.
74.
Beck KD et al. (1995) Mice homozygous for disrupted insulin-like growth factor I gene display reduced myelination in the CNS and reduced numbers of hippocampal granule and striatal parvalbumin-containing neurons. Neuron14: 717-730.
75.
Liu J-P. et al. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type 1 IGF receptor (IGF1R). Cell75: 59-72.
76.
Pardridge WM (1993) Transport of insulin-related peptides and glucose across the blood-brain barrier. Ann NY Acad Sci692: 126-137.
77.
Reinhardt RR , Bondy CA (1994) Insulin-like growth factors cross the blood-brain barrier. Endocrinology135: 1753-1761.
78.
Stong DB, Raskin R. (1993) Effects of multiple subcutaneous doses of rhIGF-1 on total and free IGF-1 levels and blood glucose in humans. Ann NY Acad Sci692: 317-320.
79.
Bondy CA et al. (1994) Clinical uses of insulin-like growth factorI. Ann Intern Med120: 593-601.
80.
Kudsk KA et al. (1994) Effect of recombinant human insulin-like growth factor-I and early total parenteral nutrition on immune depression following severe head injury. Arch Surg129: 66-71.
81.
Blakemore WF (1972) Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice. J Neurocytol1: 413-426.
82.
Collins GH et al. (1986) The histopathology of freezing injury to the rat spinal cord. A light microscopic study. I. Early degenerative changes. J Neuropathol Exp Neurol45: 721-741.
83.
Collins GH, West NR, Parmely JD (1986) The histopathology of freezing injury to the rat spinal cord. II. Repair and regeneration. J Neuropath Exp Neurol45: 742-757.
84.
Yao D-L. , Liu X., Hudson LD, Webster Hde F. (1996) Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis . Life Sci58: 1301-1306.
85.
Lannes-Vieira J., Gehrmann J., Kreutzberg GW, Wekerle H. (1994) The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rat: Distinct nature of parenchymal and perivascular infiltrates. Acta Neuropathol (Berl) 87: 435-442.
86.
Lassmann H. , Brunner C., Bradl M., Linington C. (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions . Acta Neuropathol ( Berl) 75: 566-576.
87.
Clark R. et al. (1993) Insulin-like growth factor-1 stimulation of lymphopoiesis. J Clin Invest92: 540-548.
88.
Robbins K. et al. (1994) Immunological effects of insulin-like growth factor-I-enhancement of immunoglobulin synthesis. Clin Exp Immunol95: 337-342.
89.
Li W. et al. (1996) Early insulin-like growth factor-I treatment reduces clinical deficits and lesion severity in relapses of chronic EAE. Ann Neurol [In Press].
90.
Westermark B. (1990) The molecular and cellular biology of platelet-derived growth factor. Acta Endocrinol (Copenh) 123: 131-142.
91.
Heldin C.-H, Ostman A., Westermark B. (1993) Structure of platelet-derived growth factor: Implications for functional properties. Growth Factors8: 245-252.
92.
Meyer-Ingold W., Eichner W. (1995) Platelet-derived growth factor. Cell Biol Int19: 389-398.
93.
Miura M., Li S-W., Dumenil G., Baserga R. (1994) Platelet-derived growth factor-induced expression of messenger RNA for the proliferating cell nuclear antigen requires a functional receptor for the insulin-like growth factorI. Cancer Res54: 2472-2477.
94.
Hutchins JB , Jefferson VE (1992) Developmental distribution of platelet-derived growth factor in the mouse central nervous system. Dev Brain Res67: 121-135.
95.
Hutchins JB , Zhang X. (1994) Platelet-derived growth factor (PDGF) receptors in the developing mouse optic pathway. Visual Neurosci11: 33-40.
96.
Hutchins JB (1995) Platelet-derived growth factor receptors of mouse central nervous system cells in vitro. J Comp Neurol360: 59-80.
97.
Raff MC (1989) Glial cell diversification in the rat optic nerve . Science243: 1450-1455.
98.
Miller RH, ffrench-Constant C., Raff MC ( 1989) The macroglial cells of rat optic nerve. Ann Rev Neurosci12: 547-564.
99.
Hardy R., Reynolds R. (1993) Neuron-oligodendroglial interactions during central nervous system development. J Neurosci Res36: 121-126.
100.
Zajicek J. , Compston A. (1994) Myelination in vitro of rodent dorsal root ganglia by glial progenitor cells. Brain117: 1333-1350.
101.
Miller RH (1996) Oligodendrocyte origins. Trends Neurosci19: 92-96.
102.
Wolswijk G. , Riddle PN, Noble M. (1991) Platelet-derived growth factor is mitogenic for O-2Aadult progenitor cells . Glia4: 495-503.
103.
Grinspan JB , Franceschini B. (1995) Platelet-derived growth factor is a survival factor for PSA-NCAM+ oligodendrocyte pre-progenitor cells . J Neurosci Res41: 540-551.
104.
Gard AL et al. (1995) Astroglial control of oligodendrocyte survival mediated by PDGF and leukemia inhibitory factor-like protein. Development121: 2187-2197.
105.
Honegger P. , Tenot-Sparti M. (1992) Developmental effects of basic fibroblast growth factor and platelet-derived growth factor on glial cells in a three-dimensional cell culture system. J Neuroimmunol40: 295-304.
106.
Grinspan J. , Wrabetz L., Kamholz J. (1993) Oligodendrocyte maturation and myelin gene expression in PDGF-treated cultures from rat cerebral white matter. J Neurocytol22: 322-333.
107.
Fressinaud C., Vallat JM, Pouplard-Barthelaix A. (1996) Platelet-derived growth factor partly prevents chemically induced oligodendrocyte death and improves myelin-like membrane repair in vitro. Glia16: 40-50.
108.
Daynes RA, Dowell T., Araneo BA (1991) Platelet-derived growth factor is a potent biologic response modifier of T cells. J Exp Med174: 1323-1333.
109.
Daynes RA, Araneo BA (1992) Natural regulators of T-cell lymphokine production in vivo. J Immunother12: 174-179.
110.
Burgess WH and Maciag T. (1989) The heparin-binding (fibroblast) growth factor family of proteins. Ann Rev Biochem58: 575-606.
111.
Weise B., Janet T., Grothe C. (1993) Localization of bFGF and FGF-receptor in the developing nervous system of the embryonic and newborn rat. J Neurosci Res34: 442-453.
112.
Eccleston PA, Silberberg DH (1985) Fibroblast growth factor is a mitogen for oligodendrocytes in vitro. Brain Res353: 315-318.
113.
Saneto RP, De Vellis J. (1985) Characterization of cultured rat oligodendrocytes proliferating in a serum-free, chemically defined medium. Proc Natl Acad Sci USA82: 3509-3513.
114.
Besnard F. , Perraud F., Sensenbrenner F., Labourdette G. (1989) Effects of acidic and basic fibroblast growth factors on proliferation and mautration of cultured oligodendrocytes. Int J Dev Neurosci7: 401-409.
115.
McKinnon RD , Matsui T., Dubois-Dalcq M., Aaronson SA (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development . Neuron5: 603-614.
116.
Bansal R. et al. (1996) Regulation of FGF receptors in the oligodendrocyte lineage. Mol Cell Neurosci7: 263-275.
117.
Grinspan JB , Stern JL, Franceschini B., Pleasure D. (1993) Trophic effects of basic fibroblast growth factor (bFGF) on differentiated oligodendroglia: A mechanism for regeneration of the oligodendroglial lineage . J Neurosci Res36: 672-680.
118.
Yasuda T. et al. (1995) Apoptosis occurs in the oligodendroglial lineage, and is prevented by basic fibroblast growth factor. J Neuroses Res40: 306-317.
119.
Muir DA, Compston Das. (1996) Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes. J Neurosci Res44: 1-11.
Liu HM , Chen HH (1994) Correlation between fibroblast growth factor expression and cell proliferation in experimental brain infarct: Studied with proliferating cell nuclear antigen immunohistochemistry . J Neuropathol Exp Neurol53: 118-126.
122.
Koshinaga M., Sanon HR, Whittemore SR (1993) Altered acidic and basic fibroblast growth factor expression following spinal cord injury. Exp Neurol120: 32-48.
123.
Tourbah A. et al. (1992) Endogenous aFGF expression and cellular changes after a demyelinating lesion in the spinal cord of adult normal mice: Immunohistochemical study. J Neurosci Res33: 47-59.
124.
Hughes SM et al. (1988) Ciliary neurotrophic factor induces type-2 astrocyte differentiation in culture. Nature335: 70-73.
125.
Lillien LE , Sendtner M., Raff MC (1990) Extracellular matrix-associated molecules collaborate with ciliary neurotrophic factor to induce type-2 astrocyte development. J Cell Biol112: 635 - 642.
126.
Barres BA et al. (1993) Does oligodendrocyte survival depend on axons? Curr Biol3: 489-497.
127.
D'Souza SD, Alinauskas KA, Antel JP (1996) Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res43: 289-298.
128.
Poduslo JF , Curran GL (1996) Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF . Mol Brain Res36: 280-286.
